Bioteknika Healthcare Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 31-07-2024
- Paid Up Capital ₹ 3.90 M
as on 31-07-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.35 Cr
as on 31-07-2024
- Revenue -13.20%
(FY 2023)
- Profit -8.53%
(FY 2023)
- Ebitda 74.99%
(FY 2023)
- Net Worth 10.02%
(FY 2023)
- Total Assets 63.87%
(FY 2023)
About Bioteknika Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.90 M.
The company currently has active open charges totaling ₹5.35 Cr.
Pankaj Dhole and Kuber Pandya serve as directors at the Company.
- CIN/LLPIN
U33110GJ2011PTC064291
- Company No.
064291
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bioteknika Healthcare Private Limited offer?
Bioteknika Healthcare Private Limited offers a wide range of products and services, including Biochemistry Analyzer, Fully Automated Biochemistry Analyzer, IVDs & Analyzers, Electrolyte Analyzer, Blood Collection Tubes, EDTA Tube, Science Laboratory Equipment, Mechanical Lab Equipment, Infusion Syringes & Supplies, Blood Gas Analyzer.
Who are the key members and board of directors at Bioteknika Healthcare?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pankaj Dhole | Director | 05-Mar-2011 | Current |
Kuber Pandya | Director | 05-Mar-2011 | Current |
Financial Performance of Bioteknika Healthcare.
Bioteknika Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.2% decrease. The company also saw a slight decrease in profitability, with a 8.53% decrease in profit. The company's net worth Soared by an impressive increase of 10.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bioteknika Healthcare?
In 2023, Bioteknika Healthcare had a promoter holding of 99.97% and a public holding of 0.03%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bioteknika Technologies Private LimitedActive 10 years 5 months
Pankaj Dhole and Kuber Pandya are mutual person
- Bioteknika Medical Solutions Private LimitedActive 2 years 11 months
Pankaj Dhole and Kuber Pandya are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Yes Bank Limited Creation Date: 27 Mar 2024 | ₹3.00 Cr | Open |
Others Creation Date: 17 Jun 2022 | ₹1.55 Cr | Open |
Others Creation Date: 31 May 2011 | ₹7.99 M | Open |
How Many Employees Work at Bioteknika Healthcare?
Unlock and access historical data on people associated with Bioteknika Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioteknika Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioteknika Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.